Failed Apgar scores, particularly very low scores at 5 minutes after birth, are associated with an increased risk of cerebral palsy (CP), but they do not definitively predict it on their own. The Apgar score is a quick assessment tool used immediately after birth to evaluate a newborn’s health based on five criteria: heart rate, respiratory effort, muscle tone, reflex irritability, and skin color. Scores range from 0 to 10, with lower scores indicating more severe distress. A score of 0–3 at 5 minutes is considered critically low and has been linked to higher risks of neurological complications, including CP[1][5].
Cerebral palsy is a group of permanent movement disorders caused by non-progressive disturbances in the developing brain, often related to injury or abnormal development before, during, or shortly after birth. While a low Apgar score signals that a newborn experienced significant distress, it is not a direct diagnostic tool for CP. Instead, it serves as an early warning sign that further evaluation and monitoring are necessary.
Several studies have explored the relationship between low Apgar scores and CP. For example, an Apgar score of 0–3 at 5 minutes, especially when combined with other risk factors such as extremely preterm birth, premature rupture of membranes, and moderate to severe neonatal encephalopathy (NE), correlates with a higher likelihood of adverse neurological outcomes, including CP[1]. Neonatal encephalopathy, a condition characterized by disturbed neurological function in the earliest days of life, is a strong predictor of CP, and low Apgar scores often reflect the severity of this condition[3].
However, the Apgar score alone is not sufficient to predict CP because it is influenced by many factors unrelated to brain injury, such as prematurity, maternal medications, or transient respiratory difficulties. Some infants with low Apgar scores recover fully without neurological impairment, while others with normal or near-normal scores may still develop CP due to subtle brain injuries not immediately apparent at birth[5].
Additional diagnostic tools and clinical assessments are necessary to improve prediction accuracy. These include:
– **Neonatal neurological examinations and scoring systems** such as the Thompson score, which assesses the severity of hypoxic-ischemic encephalopathy (HIE), a major cause of CP. Higher Thompson scores within the first 72 hours correlate with worse neurological prognosis[3].
– **Neuroimaging techniques** like cranial MRI, which can detect brain injuries consistent with HIE and other causes of CP. MRI abnormalities are more common in infants with moderate to severe encephalopathy and low Apgar scores but can also be present in mild cases[3].
– **Biomarkers** such as serum high-mobility group box 1 (HMGB1) protein levels, which have been associated with brain injury severity and prognosis in neonates with low Apgar scores and encephalopathy[1].
– **Continuous brain monitoring** using amplitude-integrated EEG (aEEG) within the first hours of life helps identify infants at risk for adverse outcomes, including CP[3].
It is also important to consider that genetic factors can contribute to CP risk independently of birth asphyxia or low Apgar scores. Recent research has identified pathogenic genetic variants in individuals diagnosed with CP, indicating that some cases arise from inherited or spontaneous mutations affecting brain development[6].
In summary
